• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霍乱毒素佐剂对口服或鼻饲卵清蛋白的IgE抗体反应的影响。

Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin.

作者信息

Tamura S, Shoji Y, Hasiguchi K, Aizawa C, Kurata T

机构信息

Department of Pathology, National Institute of Health, Tokyo, Japan.

出版信息

Vaccine. 1994 Oct;12(13):1238-40. doi: 10.1016/0264-410x(94)90250-x.

DOI:10.1016/0264-410x(94)90250-x
PMID:7839730
Abstract

Effects of cholera toxin B subunits supplemented with 0.1% cholera toxin (CTB*) on systemic IgE antibody responses to ovalbumin (OVA) were examined in BDFI (H-2b/d), Balb/c (H-2d) and C3H (H-2k) mice given OVA intragastrically or intranasally. Two successive doses of OVA intragastrically administered to Balb/c and C3H mice induced little IgE response and resulted in almost complete unresponsiveness to subsequent intraperitoneal challenge with OVA in Al(OH)3, while the intragastric administration to BDF1 mice induced high IgE response and resulted in abrogation of the unresponsiveness to the subsequent challenge. The intranasal administration of OVA induced little IgE response and suppressed response to the subsequent challenge in any strain of mice. On the other hand, two successive doses of intragastric or intranasal OVA together with CTB* enhanced IgE response in all three strains and the subsequent challenge with OVA in Al(OH)3 induced higher IgE responses. These results suggest that CTB* augments IgE response to OVA and abrogates the unresponsiveness when administered orally or intranasally into mice together with OVA, regardless of the H-2 haplotype of the mice.

摘要

在经口或经鼻给予卵清蛋白(OVA)的BDFI(H-2b/d)、Balb/c(H-2d)和C3H(H-2k)小鼠中,研究了补充0.1%霍乱毒素的霍乱毒素B亚基(CTB*)对OVA全身性IgE抗体反应的影响。向Balb/c和C3H小鼠经口连续给予两剂OVA诱导出很少的IgE反应,并导致对随后用氢氧化铝佐剂的OVA腹腔攻击几乎完全无反应,而向BDF1小鼠经口给药诱导出高IgE反应,并消除了对随后攻击的无反应性。经鼻给予OVA在任何品系小鼠中诱导出很少的IgE反应,并抑制了对随后攻击的反应。另一方面,经口或经鼻连续给予两剂OVA与CTB一起增强了所有三个品系中的IgE反应,并且随后用氢氧化铝佐剂的OVA攻击诱导出更高的IgE反应。这些结果表明,当与OVA一起经口或经鼻给予小鼠时,CTB增强了对OVA的IgE反应并消除了无反应性,而与小鼠的H-2单倍型无关。

相似文献

1
Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin.霍乱毒素佐剂对口服或鼻饲卵清蛋白的IgE抗体反应的影响。
Vaccine. 1994 Oct;12(13):1238-40. doi: 10.1016/0264-410x(94)90250-x.
2
Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract.脂质体偶联卵清蛋白对经呼吸道用卵清蛋白致敏小鼠特异性IgE抗体反应的抑制作用。
Int Arch Allergy Immunol. 2000 Feb;121(2):108-15. doi: 10.1159/000024305.
3
Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.用霍乱毒素B亚基佐剂进行经皮免疫通过选择性诱导Th1免疫反应来抑制IgE抗体反应。
J Immunol. 2003 Feb 1;170(3):1586-92. doi: 10.4049/jimmunol.170.3.1586.
4
Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice.用与霍乱毒素B亚基偶联的低剂量变应原进行长时间口服治疗可抑制致敏小鼠的免疫球蛋白E抗体反应。
Clin Exp Allergy. 2000 Jul;30(7):1024-32. doi: 10.1046/j.1365-2222.2000.00849.x.
5
Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.舌下给予天然或变性蛋白过敏原与佐剂CpG寡脱氧核苷酸或霍乱毒素对小鼠全身Th2免疫反应和黏膜免疫的影响。
Ann Allergy Asthma Immunol. 2007 Nov;99(5):443-52. doi: 10.1016/S1081-1206(10)60570-4.
6
Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.重新审视口服耐受:先前的口服耐受可消除霍乱毒素诱导的黏膜IgA反应。
J Immunol. 2001 Mar 1;166(5):3114-21. doi: 10.4049/jimmunol.166.5.3114.
7
A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization.天然霍乱毒素B亚基与重组霍乱毒素B亚基作为鼻内免疫刺激因子的比较。
Vaccine. 1997 Jul;15(10):1110-3. doi: 10.1016/s0264-410x(97)00007-8.
8
Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.用来自HIV-1或卵清蛋白的CTL表位肽以及粘膜佐剂霍乱毒素进行鼻内免疫,可诱导肽特异性CTL,并在体内预防肿瘤发展。
J Immunol. 1997 Jan 15;158(2):834-41.
9
Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.在I型过敏小鼠模型中,变应原/霍乱类毒素(CTB)偶联物的抑制与刺激作用取决于变应原的性质
Int Immunol. 1999 Jul;11(7):1131-8. doi: 10.1093/intimm/11.7.1131.
10
Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.经鼻腔给药的霍乱毒素A亚单位可作为一种黏膜佐剂。
J Oral Sci. 2003 Mar;45(1):25-31. doi: 10.2334/josnusd.45.25.

引用本文的文献

1
Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF-10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses.鼻腔内接种使用新型合成黏膜佐剂 SF-10 进行流感疫苗接种:诱导强大的局部和全身免疫,同时平衡 Th1 和 Th2 反应。
Influenza Other Respir Viruses. 2013 Nov;7(6):1218-26. doi: 10.1111/irv.12124. Epub 2013 May 26.
2
Intranasal immunization with synthetic peptides corresponding to the E6 and E7 oncoproteins of human papillomavirus type 16 induces systemic and mucosal cellular immune responses and tumor protection.用与人乳头瘤病毒16型E6和E7癌蛋白对应的合成肽进行鼻内免疫可诱导全身和黏膜细胞免疫反应以及肿瘤保护。
Vaccine. 2007 Apr 30;25(17):3302-10. doi: 10.1016/j.vaccine.2007.01.010. Epub 2007 Jan 24.
3
Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells.重组抗原 - 肠毒素A2/B嵌合黏膜免疫原可不同程度地增强抗体反应以及B7依赖的CD4(+) T细胞共刺激。
Infect Immun. 2001 Jan;69(1):252-61. doi: 10.1128/IAI.69.1.252-261.2001.
4
Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor beta1 and beta2 chain expression.霍乱毒素可抑制白细胞介素(IL)-12的产生以及IL-12受体β1和β2链的表达。
J Exp Med. 1999 Feb 1;189(3):541-52. doi: 10.1084/jem.189.3.541.
5
Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen.佐剂对变应原吸入小鼠模型中变应原免疫反应的影响:霍乱毒素诱导对主要桦树花粉变应原Bet v 1的Th1样反应。
Clin Exp Immunol. 1998 Jan;111(1):144-51. doi: 10.1046/j.1365-2249.1998.00477.x.
6
Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.用重组霍乱毒素B亚单位对人类进行鼻内接种可在上呼吸道和阴道诱导全身和局部抗体反应。
Infect Immun. 1997 Jul;65(7):2676-84. doi: 10.1128/iai.65.7.2676-2684.1997.
7
Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.用弓形虫SAG1蛋白联合霍乱毒素进行鼻内免疫,可显著减少口服感染后脑囊肿的形成。
Infect Immun. 1996 Jun;64(6):2158-66. doi: 10.1128/iai.64.6.2158-2166.1996.
8
Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit.用细菌蛋白抗原和霍乱毒素B亚单位经鼻内免疫的猴子的唾液、鼻腔、生殖器及全身抗体反应。
Infect Immun. 1996 Apr;64(4):1272-83. doi: 10.1128/iai.64.4.1272-1283.1996.
9
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.一种缺乏ADP-核糖基转移酶活性的突变型百日咳毒素分子PT-9K/129G,是经鼻递送蛋白质的有效黏膜佐剂。
Infect Immun. 1995 Jun;63(6):2100-8. doi: 10.1128/iai.63.6.2100-2108.1995.